Cargando…

suPAR Cut-Offs for Risk Stratification in Patients With Symptoms of COVID-19

OBJECTIVES: Elevated soluble urokinase Plasminogen Activator Receptor (suPAR) is a biomarker associated with adverse outcomes. We aimed to investigate the associations between plasma suPAR levels (testing the cut-offs ⩽4, 4-6, and ⩾6 ng/mL) with risk of 14-day mortality, and with the risk of mechani...

Descripción completa

Detalles Bibliográficos
Autores principales:	Altintas, Izzet, Eugen-Olsen, Jesper, Seppälä, Santeri, Tingleff, Jens, Stauning, Marius Ahm, El Caidi, Nora Olsen, Elmajdoubi, Sanaá, Gamst-Jensen, Hejdi, Lindstrøm, Mette B, Rasmussen, Line Jee Hartmann, Kristiansen, Klaus Tjelle, Rasmussen, Christian, Nehlin, Jan O, Kallemose, Thomas, Hyppölä, Harri, Andersen, Ove
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371731/ https://www.ncbi.nlm.nih.gov/pubmed/34421295 http://dx.doi.org/10.1177/11772719211034685

Ejemplares similares

Soluble Urokinase Plasminogen Activator Receptor as a Decision Marker for Early Discharge of Patients with COVID-19 Symptoms in the Emergency Department
por: Stauning, Marius Ahm, et al.
Publicado: (2021)

suPAR cut-offs for stratification of low, medium, and high-risk acute medical patients in the emergency department
por: Santeri, Seppälä, et al.
Publicado: (2021)

Healthy lifestyles reduce suPAR and mortality in a Danish general population study
por: Haupt, Thomas Huneck, et al.
Publicado: (2019)

Elevated suPAR Is an Independent Risk Marker for Incident Kidney Disease in Acute Medical Patients
por: Iversen, Esben, et al.
Publicado: (2020)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) in the Emergency Department (Ed): A Tool for the Assessment of Elderly Patients
por: Holstein, Ria M., et al.
Publicado: (2022)

High suPAR and Low Blood Eosinophil Count are Risk Factors for Hospital Readmission and Mortality in Patients with COPD
por: Håkansson, Kjell E J, et al.
Publicado: (2020)

The biomarkers suPAR and blood eosinophils are associated with hospital readmissions and mortality in asthma – a retrospective cohort study
por: Håkansson, K. E. J., et al.
Publicado: (2019)

suPAR is associated with risk of future acute surgery and post-operative mortality in acutely admitted medical patients
por: Meyer, Jeppe, et al.
Publicado: (2018)

Availability of suPAR in emergency departments may improve risk stratification: a secondary analysis of the TRIAGE III trial
por: Schultz, Martin, et al.
Publicado: (2019)

Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation
por: Rasmussen, Line Jee Hartmann, et al.
Publicado: (2021)

Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis
por: Garnæs, Emilie, et al.
Publicado: (2019)

Early Discharge from the Emergency Department Based on Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels: A TRIAGE III Substudy
por: Schultz, Martin, et al.
Publicado: (2019)

COVID-19 mortality among selective serotonin reuptake inhibitor users—results from a nationwide cohort
por: Stauning, Marius Ahm, et al.
Publicado: (2023)

Short Communication: Opportunities and Challenges for Early Person-Centered Care for Older Patients in Emergency Settings
por: Jensen, Andrea N., et al.
Publicado: (2021)

Combining National Early Warning Score With Soluble Urokinase Plasminogen Activator Receptor (suPAR) Improves Risk Prediction in Acute Medical Patients: A Registry-Based Cohort Study*
por: Rasmussen, Line J. H., et al.
Publicado: (2018)

Self-rated health and chronic inflammation are related and independently associated with hospitalization and long-term mortality in the general population
por: Tavenier, Juliette, et al.
Publicado: (2022)

SuPAR - A future prognostic biomarker in emergency medicine
por: Østervig, Rebecca M, et al.
Publicado: (2015)

Soluble urokinase plasminogen activator receptor (suPAR) as a prognostic marker of mortality in healthy, general and patient populations: protocol for a systematic review and meta-analysis
por: Petersen, Jens Emil Vang, et al.
Publicado: (2020)

Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study
por: Rasmussen, Line Jee Hartmann, et al.
Publicado: (2016)

Soluble urokinase plasminogen activator receptor and decline in kidney function among patients without kidney disease
por: Iversen, Esben, et al.
Publicado: (2022)

Stressful Life Events and Inflammation in Midlife: Comparing Associations With suPAR, CRP, and IL-6
por: Bourassa, Kyle, et al.
Publicado: (2020)

suPAR: The Molecular Crystal Ball
por: Thunø, Maria, et al.
Publicado: (2009)

Association Between Elevated suPAR, a New Biomarker of Inflammation, and Accelerated Aging
por: Rasmussen, Line Jee Hartmann, et al.
Publicado: (2020)

Utility of suPAR and NGAL for AKI Risk Stratification and Early Optimization of Renal Risk Medications among Older Patients in the Emergency Department
por: Walls, Anne Byriel, et al.
Publicado: (2021)

Use of the prognostic biomarker suPAR in the emergency department improves risk stratification but has no effect on mortality: a cluster-randomized clinical trial (TRIAGE III)
por: Schultz, Martin, et al.
Publicado: (2018)

Risk Factors Associated with Serum Levels of the Inflammatory Biomarker Soluble Urokinase Plasminogen Activator Receptor in a General Population
por: Haupt, Thomas H, et al.
Publicado: (2014)

Inflammatory biomarkers and cancer: CRP and suPAR as markers of incident cancer in patients with serious nonspecific symptoms and signs of cancer
por: Rasmussen, Line Jee Hartmann, et al.
Publicado: (2017)

Associations between degree-of-worry, self-rated health and acute hospitalisation after contacting a medical helpline: a Danish prospective cohort study
por: Jensen, Andrea Nedergaard, et al.
Publicado: (2021)

SuPAR predicts postoperative complications and mortality in patients with asymptomatic aortic stenosis
por: Hodges, Gethin W, et al.
Publicado: (2018)

Leptin, IL-6, and suPAR reflect distinct inflammatory changes associated with adiposity, lipodystrophy and low muscle mass in HIV-infected patients and controls
por: Langkilde, Anne, et al.
Publicado: (2015)

Prognostic value of suPAR and hsCRP on acute kidney injury after cardiac surgery
por: Rasmussen, Sebastian Roed, et al.
Publicado: (2021)

Plasma suPAR levels are associated with mortality, admission time, and Charlson Comorbidity Index in the acutely admitted medical patient: a prospective observational study
por: Haupt, Thomas Huneck, et al.
Publicado: (2012)

Serum soluble urokinase plasminogen activator receptor (suPAR) in adults with growth hormone deficiency
por: Höybye, Charlotte, et al.
Publicado: (2019)

Under-triage in telephone consultation is related to non-normative symptom description and interpersonal communication: a mixed methods study
por: Gamst-Jensen, Hejdi, et al.
Publicado: (2017)

BIOLOGICAL AGING IS ASSOCIATED WITH INCREASED MONOCYTE INFLAMMATORY ACTIVITY IN OLDER ADULTS
por: Tavenier, Juliette, et al.
Publicado: (2019)

Soluble urokinase plasminogen activator receptor (suPAR) is a novel, independent predictive marker of myocardial infarction in HIV‐1‐infected patients: a nested case‐control study
por: Rasmussen, LJH, et al.
Publicado: (2015)

suPAR and Team Nephrology
por: Trachtman, Howard
Publicado: (2014)

Utility of the Plasma Level of suPAR in Monitoring Risk of Mortality during TB Treatment
por: Rabna, Paulo, et al.
Publicado: (2012)

SuPAR in major depression: Association with 26 weeks antidepressant response and 10-year depression outcomes
por: Haupt, T.H., et al.
Publicado: (2023)

suPAR: An Inflammatory Mediator for Kidneys
por: Sudhini, Yashwanth Reddy, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lcemib6l6t0r8e30gpavcdtso4